Expected earnings - LB Pharmaceuticals Inc
Source: US Earnings Reports
LB Pharmaceuticals Inc (LBRX) is expected to report $-0.45 for Q4 2025
LB Pharmaceuticals Inc
NASDAQ: LBRX
LBRX Trading
0.25% G/L:
$24.49 Last:
106,215 Volume:
$24.71 Open:
LBRX Latest News
March 09, 2026 08:00:00 am
LB Pharmaceuticals Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors
February 27, 2026 11:44:00 am
Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments
LBRX Stock Data
$612,744,250
14,088,311
0.56%
11
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
